BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 16421159)

  • 1. Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study.
    Hoffmann U; Segerer S; Rümmele P; Krüger B; Pietrzyk M; Hofstädter F; Banas B; Krämer BK
    Nephrol Dial Transplant; 2006 May; 21(5):1373-81. PubMed ID: 16421159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CXCR3 in cellular but not humoral renal allograft rejection.
    Segerer S; Böhmig GA; Exner M; Kerjaschki D; Regele H; Schlöndorff D
    Transpl Int; 2005 Jun; 18(6):676-80. PubMed ID: 15910293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SDF-1 expression is elevated in chronic human renal allograft rejection.
    Hoffmann U; Banas B; Krüger B; Banas M; Bergler T; Böger C; Kammerl M; Obed A; Rümmele P; Segerer S; Riegger GA; Krämer BK
    Clin Transplant; 2006; 20(6):712-8. PubMed ID: 17100720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
    Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation.
    Inston N; Drayson M; Ready A; Cockwell P
    Exp Clin Transplant; 2007 Dec; 5(2):638-42. PubMed ID: 18194114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of chemokine receptor CX3CR1 in human renal allograft rejection.
    Hoffmann U; Bergler T; Segerer S; Rümmele P; Krüger B; Banas MC; Reinhold S; Banas B; Krämer BK
    Transpl Immunol; 2010 Aug; 23(4):204-8. PubMed ID: 20600902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis.
    Segerer S; Banas B; Wörnle M; Schmid H; Cohen CD; Kretzler M; Mack M; Kiss E; Nelson PJ; Schlöndorff D; Gröne HJ
    Am J Pathol; 2004 Feb; 164(2):635-49. PubMed ID: 14742268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the chemokine receptor CCR1 in human renal allografts.
    Mayer V; Hudkins KL; Heller F; Schmid H; Kretzler M; Brandt U; Anders HJ; Regele H; Nelson PJ; Alpers CE; Schlöndorff D; Segerer S
    Nephrol Dial Transplant; 2007 Jun; 22(6):1720-9. PubMed ID: 17298994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute kidney graft rejection morphology and immunology.
    Andersen CB
    APMIS Suppl; 1997; 67():1-35. PubMed ID: 9063492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of endothelin-1 (ET-1) in human acute renal allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2003; 54(2):95-100. PubMed ID: 14575417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal peritubular capillary C4d deposition in acute rejection.
    Magil AB; Tinckam KJ
    Nephrol Dial Transplant; 2006 May; 21(5):1382-8. PubMed ID: 16396975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients.
    Stallone G; Infante B; Schena A; Battaglia M; Ditonno P; Loverre A; Gesualdo L; Schena FP; Grandaliano G
    J Am Soc Nephrol; 2005 Dec; 16(12):3755-62. PubMed ID: 16236802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
    Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA fragmentation in acute and chronic rejection after renal transplantation.
    Ott U; Aschoff A; Fünfstück R; Jirikowski G; Wolf G
    Transplant Proc; 2007; 39(1):73-7. PubMed ID: 17275477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection.
    Kakuta Y; Okumi M; Miyagawa S; Tsutahara K; Abe T; Yazawa K; Matsunami K; Otsuka H; Takahara S; Nonomura N
    Transplantation; 2012 Jan; 93(1):24-31. PubMed ID: 22124337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection.
    Panzer U; Reinking RR; Steinmetz OM; Zahner G; Sudbeck U; Fehr S; Pfalzer B; Schneider A; Thaiss F; Mack M; Conrad S; Huland H; Helmchen U; Stahl RA
    Transplantation; 2004 Nov; 78(9):1341-50. PubMed ID: 15548973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.